Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€41.21

€41.21

3.890%
1.54
3.890%
€70.67
 
24.07.24 / Tradegate WKN: 850501 / Symbol: BMY / Name: Bristol-Myers / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Bristol-Myers Squibb Stock

A very strong showing by Bristol-Myers Squibb today, with an increase of €1.54 (3.890%) compared to yesterday's price.
We see a rather positive sentiment for Bristol-Myers Squibb with 9 Buy predictions and 2 Sell predictions.
With a target price of 70 € there is a hugely positive potential of 69.86% for Bristol-Myers Squibb compared to the current price of 41.21 €.
Our community identified positive and negative aspects for Bristol-Myers Squibb stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bristol-Myers Squibb stock. On the other hand our users think that "Business model" could be a problem in the future.

Pros and Cons of Bristol-Myers Squibb in the next few years

Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Bristol-Myers Squibb vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Bristol-Myers Squibb 3.890% 4.382% 4.753% -29.676% -11.185% -29.009% 5.952%
Johnson & Johnson 2.580% 0.740% 3.830% -6.774% 1.850% -1.179% 23.794%
Elanco Animal Health Inc. 1.580% -1.607% -30.491% 7.835% -13.062% -62.096% -
Biogen Inc. 0.970% -0.144% -1.185% -16.733% -11.578% -24.525% -3.828%

Comments

Prediction Buy
Perf. (%) -8.31%
Target price 61.404
Change
Ends at 27.12.24

Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Bank of America Co. from $72.00 to $68.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -11.16%
Target price 65.026
Change
Ends at 30.10.24

Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat
Show more

Prediction Sell
Perf. (%) -13.93%
Target price 47.310
Change
Ends at 27.10.24

Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Morgan Stanley from $56.00 to $50.00. They now have an "underweight" rating on the stock.
Ratings data for BMY provided by MarketBeat
Show more